Vitalhub (VHI) 2nd Annual Lytham Partners Healthcare Investor Summit summary
Event summary combining transcript, slides, and related documents.
2nd Annual Lytham Partners Healthcare Investor Summit summary
15 Jan, 2026Business overview and market focus
Operates as a healthcare IT software vendor serving government-funded healthcare systems internationally, with key markets in Canada, the UK, Australia, the Middle East, and Europe.
Focuses on enterprise solutions for hospitals and government agencies overseeing healthcare networks, emphasizing patient flow and integration across care settings.
Differentiates through a comprehensive suite of solutions, including AI enhancements, supporting patient navigation from primary care to long-term and home care.
Customer base is primarily hospitals and government agencies, with a growing emphasis on system integration and patient movement across care environments.
Sales are mainly direct, with partnerships for knowledge and change management, and contracts are typically long-term and mission-critical.
Growth strategy and financial profile
Growth is driven by both organic expansion and strategic acquisitions, with 23 acquisitions completed to date.
Organic growth levers include upselling new modules, cross-pollination between customer bases, and achieving preferred vendor status.
Acquisition targets are financially healthy or improvable companies with compatible technology and potential for integration and profitability.
Offshore development in Sri Lanka supports cost-effective innovation and integration of acquired businesses.
80% of revenue is recurring, with CAD 94 million ARR, no debt, and CAD 120 million in cash; gross profit margin is 80-81%.
Forward-looking statements and operational goals
Plans to continue selective acquisitions, aiming for three to four per year, with a focus on integrating recent large acquisitions and restoring adjusted EBITDA margins.
Targets adjusted EBITDA margins of 25-27% as integration synergies are realized, aiming to return to Rule of 40 performance.
Expects to leverage AI to add new modules and drive ARR growth, with significant impact anticipated by late 2026 and into 2027.
Maintains a strong cash position to support ongoing M&A and operational initiatives.
Confident in execution of the consolidation model and continued operational improvements.
Latest events from Vitalhub
- ARR and revenue surged in 2025, with strong EBITDA growth and cash for acquisitions.VHI
Q4 202519 Mar 2026 - Q2 revenue up 24% with 41% higher adjusted EBITDA and MedCurrent acquisition pending.VHI
Q2 20241 Feb 2026 - Delivers $93.7M ARR and 22% EBITDA margin through global healthcare software and M&A.VHI
Investor presentation15 Jan 2026 - Q3 revenue and ARR up 25%, pro forma ARR at CAD 68M after acquisitions, strong cash position.VHI
Q3 202413 Jan 2026 - Healthcare IT firm achieves $70M+ ARR via acquisitions, organic growth, and high-margin solutions.VHI
Planet MicroCap Showcase: VEGAS 202527 Dec 2025 - ARR up 59% and revenue up 31% in 2024, with robust M&A and strong cash position.VHI
Q4 202426 Dec 2025 - Q1 2025 delivered robust ARR and revenue growth, with strong M&A momentum and cash position.VHI
Q1 202526 Nov 2025 - ARR up 55%, revenue up 47%, 26% EBITDA margin, and strong acquisition integration.VHI
Q2 202523 Nov 2025 - ARR up 75% YoY to CAD 93.7M; Q3 revenue up 94%; integration and margin focus ongoing.VHI
Q3 202513 Nov 2025